These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24111840)

  • 41. A sparse Ising model with covariates.
    Cheng J; Levina E; Wang P; Zhu J
    Biometrics; 2014 Dec; 70(4):943-53. PubMed ID: 25099186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reclassification of predictions for uncovering subgroup specific improvement.
    Biswas S; Arun B; Parmigiani G
    Stat Med; 2014 May; 33(11):1914-27. PubMed ID: 24353130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.
    Strandberg R; Czene K; Eriksson M; Hall P; Humphreys K
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):569-577. PubMed ID: 35027432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis.
    Liao SH; Hung CC; Chen CN; Yen JY; Hsu CY; Yen AM; Chen CL
    J Formos Med Assoc; 2021 Jun; 120 Suppl 1():S77-S85. PubMed ID: 34074579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach.
    Jen HH; Chang WJ; Lin TY; Hsu CY; Yen AM; Lai CC; Chen TH
    Infect Dis Ther; 2021 Jun; 10(2):815-825. PubMed ID: 33738764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Precision Science on Incidence and Progression of Early-Detected Small Breast Invasive Cancers by Mammographic Features.
    Chang RW; Chuang SL; Hsu CY; Yen AM; Wu WY; Chen SL; Fann JC; Tabar L; Smith RA; Duffy SW; Chiu SY; Chen HH
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data.
    Abrahamsson L; Czene K; Hall P; Humphreys K
    Breast Cancer Res; 2015 Aug; 17():116. PubMed ID: 26293658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan.
    Hsieh HJ; Chen TH; Chang SH
    Stat Med; 2002 Nov; 21(22):3369-82. PubMed ID: 12407678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A bayesian random-effects markov model for tumor progression in women with a family history of breast cancer.
    Hui-Min Wu G; Chang SH; Hsiu-Hsi Chen T
    Biometrics; 2008 Dec; 64(4):1231-7. PubMed ID: 18218063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
    Musolino A; Bella MA; Bortesi B; Michiara M; Naldi N; Zanelli P; Capelletti M; Pezzuolo D; Camisa R; Savi M; Neri TM; Ardizzoni A
    Breast; 2007 Jun; 16(3):280-92. PubMed ID: 17257844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer.
    Yen AM; Wu WY; Tabar L; Duffy SW; Smith RA; Chen HH
    J Epidemiol; 2017 Mar; 27(3):98-106. PubMed ID: 28142043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular testing in breast cancer.
    Paoletti C; Hayes DF
    Annu Rev Med; 2014; 65():95-110. PubMed ID: 24422569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk assessment of multistate progression of breast tumor with state-dependent genetic and environmental covariates.
    Wu YY; Yen MF; Yu CP; Chen HH
    Risk Anal; 2014 Feb; 34(2):367-79. PubMed ID: 24111840
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.